Abstract: A powder inhaler includes a casing having a mouthpiece and housing an inhalation channel connected to an opening of the mouthpiece, a container for storing a powdered medicament and placed in the casing, a cover engageable with the casing to close the mouthpiece. The cover includes a sealing element made of a material that is more deformable than a material of the mouthpiece such that, when the cover is engaged with the casing and closes the mouthpiece, a main portion of the sealing element is coupled to the opening to tight close the opening.

Abstract: A drug product includes a multidose dry powder inhalation device. The device has a medicament chamber and a desiccant chamber adjacent to the medicament chamber, and a pharmaceutical composition therein. The pharmaceutical composition includes a pharmaceutically acceptable salt of tanimilast. The desiccant chamber is filled with molecular sieves.

Abstract: A powder inhaler includes a casing having a mouthpiece, an inhalation channel, a container for a powdered medicament, and a metering device with a shuttle having a dosing recess. The shuttle is movable between a filling position, in which the dosing recess is in alignment with an opening of the container to be filled with a dose of the powdered medicament, and an inhalation position, in which the dosing recess is in alignment with the inhalation channel, for enabling inhalation of the dose of the powdered medicament contained in the dosing recess through the mouthpiece. A sealing device is operationally active at a coupling zone of the shuttle with the container when the shuttle is in the filling position, the coupling zone circumscribing the dosing recess and the opening.

Abstract: A drug product includes a multidose dry powder inhalation device. The device has a medicament chamber and a desiccant chamber adjacent to the medicament chamber, and a pharmaceutical composition therein. The pharmaceutical composition includes a pharmaceutically acceptable salt of formoterol, optionally in combination with a pharmaceutically acceptable salt of glycopyrronium and/or beclomethasone dipropionate. The desiccant chamber is filled with molecular sieves.

Abstract: A filter assembly comprising a prefiltering support layer (84) is disclosed, wherein the prefiltering support layer (84) comprises a non-woven fabric of fibers, the non-woven fabric having a pore size. A first mesh filter layer (85) is arranged downstream the prefiltering support layer (84), wherein the first mesh filter layer (85) has a first mesh size, wherein the pore size of the prefiltering support layer (84) is equal to or bigger than the first mesh size of the first mesh filter layer (85). A container for collecting a body fluid comprising such a filter assembly as well as a method for manufacturing such a filter assembly are also disclosed.